Curis | CRIS - Операционные расходы





Операционные расходы Изменить Дата
Alaunos Therapeutics USD 952K 60K 2026-06
Amgen USD 5.69B 6B 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Bayer EUR 9.92B 121M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
CSL USD 5.7B 2.82B 2025-12
Curis USD 11.52M 2.5M 2026-03
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 390.27M 10M 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Incyte USD 5.64B 4.67B 2026-09
Merck USD 10.75B 5.02B 2026-09
Novartis USD 9.88B 325M 2026-09
Pfizer USD 89B 3.81B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
Takeda JPY 981.78B 36.71B 2026-09
TG Therapeutics USD 218.66M 48.54M 2026-06
Verastem USD 63.57M 4.56M 2026-03